Search Results

SEARCH RESULTS

Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.

READ MORE

Recently, mental health advocates and industry leaders came together in Chicago for New Cures, New Innovation for a New Era in Mental Health–hosted by America's…

READ MORE

At a recent event held by The Atlantic, scientists and researchers joined others in the biopharmaceutical industry to discuss genomics' ever-evolving and critically…

READ MORE

DNA damage response (DDR) is a term used to describe the network of cellular pathways that minimize the daily impact of DNA damage.

READ MORE

Nowhere is the partnership between technology and medicine evolving so strongly and quickly than the Bay Area of California.

READ MORE

Treating patients struggling with mental illness is decidedly one of the most challenging tasks in modern medicine.

READ MORE

We are on the cusp of a major, positive disruption in the U.S. health care system due in part to the exponential growth in clinical data, advent and incorporation of…

READ MORE

Experts come together for a dialogue focused on the future of genomics, and specifically how genetic mapping will continue to empower leading scientific minds to…

READ MORE

Treating patients with mental health disorders is about getting to know the person behind the disease. More than any other branch of medicine, psychiatry involves…

READ MORE

A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals -…

READ MORE